My favorate stock :: essays research papers

Stock s stamp out for ADVANCED NEUROMODULATION SYSTEMS INC.Stock symbol AISI.OSECTOR HealthcareINDUSTRY aesculapian Equipment & SuppliesOverview go on Neuromodulation Systems, Inc. (ANSI), designs, develops, manufactures and markets advanced implantable neuromodulation devices that improve the quality of life for people crucifixion from chronic pain. Neuromodulation devices include implantable neurostimulation devices, which deliver electric current directly to targeted nerves, and implantable do drugs pumps, which deliver small, precisely controlled doses of drugs directly to targeted sites within the body.GROWTH RATES1 Year3 Years5 YearsSales %32.5747.1227.54EPS %33.80103.4515.06Dividend %NMNMNMREVENUEQuarters2001200220032004MAR8,34111,47319,67126,633JUN9,20513,42322,32430,488 phratry9,90014,32823,41931,330 downslope10,47018,14825,66832,293Totals37,91657,37291,082120,744Note Units in Thousands of U.S. DollarsEARNINGS PER SHAREQuarters2001200220032004MAR0.0000.0530.1330.190JUN0. 0270.0900.1400.210SEP0.0330.1000.1900.230DEC0.0470.1270.1800.240Totals0.1070.3700.6430.870Note Units in U.S. DollarsQuick Financial Synopsis Advanced Neuromodulation Systems designs, develops, manufactures and markets implantable neuromodulation for chronic back pain or nervous system disorders. For the FY stop 12/31/04, revenues rose 33% to $120.7M. Net income rose 37% to $18.2M. Revenues reflect change magnitude unit sales from Neuro Products and O.E.M. business segments. Net income overly reflects increased operating margin as well as increased investment income. positive revenue and EPS for the latest fiscal yearActual revenue $US 120.7 millionsRecent share price and date$US 27.23March 29, 2005Month of the companys fiscal year endDecemberIndicate annual dividend per share0.00ValuationValuation proportionalitysproportion COMPARISONValuation Ratios come withIndustrySectorS&P 500P/E Ratio (TTM)32.5433.5528.9721.43P/E high - work 5 Yrs.NM60.5450.3042.31P/E Low - Last 5 Yrs.20. 8822.6519.8815.75Price to Sales (TTM)4.894.945.212.87Price to Book (MRQ)2.555.534.993.92Price to evident Book (MRQ)3.0413.9411.837.15Price to cash Flow (TTM)23.5524.9321.9114.76Price to Free Cash Flow (TTM)367.7632.7230.1825.30% Owned Institutions95.0028.5647.2665.58DividendsDividendsCompanyIndustrySectorS&P 500Dividend YieldNA0.792.172.12Dividend Yield - 5 Year Avg.0.000.451.041.58Dividend 5 Year Growth RateNM10.5411.379.06Payout Ratio (TTM)0.0015.0229.3829.26Growth placeGrowth Rates (%)CompanyIndustrySectorS&P 500Sales (MRQ) vs. Qtr. 1 Yr. agone25.8119.3315.0717.60Sales (TTM) vs TTM 1 Yr. Ago32.5722.6716.3315.81Sales - 5 Yr. Growth Rate27.5415.8816.019.76EPS (MRQ) vs Qtr. 1 Yr. Ago36.7213.870.4716.59EPS (TTM) vs TTM 1 Yr. Ago34.0124.509.6824.79EPS - 5 Yr. Growth Rate15.0627.2016.0113.64Capital Spending - 5 Yr. Growth Rate24.4213.3311.593.15Financial StrengthFinancial StrengthCompanyIndustrySectorS&P 500Quick Ratio (MRQ)15.841.991.941.20Current Ratio (MRQ)18.782.792.541.69LT Debt to Equity (MRQ)0.000.380.370.63Total Debt to Equity (MRQ)0.000.440.440.79Interest reportage (TTM)NM17.3810.8111.87Profitability RatiosProfitability Ratios (%)CompanyIndustrySectorS&P 500Gross Margin (TTM)73.4263.6768.9246.09Gross Margin - 5 Yr. Avg.64.0262.1268.2945.61EBITD Margin (TTM)23.8723.6624.6821.60EBITD - 5 Yr.